Physician profile
Naved Jafri
NPI 1750391355
$6,439.78
in general payments reported to CMS, 2019-2025
38 companies · $511 in 2025
The $511 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $399 · 2021: $3,618 · 2022: $668 · 2023: $629 · 2024: $232 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,833.88 | 2021 | |
| Axonics, INC. | $1,478.77 | 2020-2023 | Axonics |
| Astellas Pharma US INC | $476.84 | 2019-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $353.19 | 2019-2025 | |
| Daiichi Sankyo INC. | $272.54 | 2021-2025 | Injectafer |
| Sumitomo Pharma America, INC. | $149.25 | 2023-2025 | Myfembree, Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $123.97 | 2025 | Caplyta |
| Mayne Pharma Commercial LLC | $118.12 | 2022-2023 | |
| Hologic Sales and Service, LLC | $99.47 | 2019-2023 | Acessa Provu System, Aptima |
| Karl Storz Endoscopy-America | $91.36 | 2022-2023 | N.A. |
| Minerva Surgical, INC | $87.49 | 2019-2025 | |
| Boston Scientific Corporation | $85.35 | 2019-2023 | Upsylon |
| Allergan, INC. | $84.94 | 2019-2020 | |
| Pfizer INC. | $81.83 | 2019-2025 | |
| Therapeuticsmd, INC. | $80.08 | 2019-2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $76.07 | 2020-2023 | Altis |
| Myovant Sciences INC. | $71.59 | 2022 | |
| Urovant Sciences INC | $69.99 | 2021-2022 | |
| Organon LLC | $67.47 | 2022-2024 | |
| Coopersurgical, INC. | $66.49 | 2019-2025 | Ally II Ups, Paragard T 380a |
| Caldera Medical, INC | $64.03 | 2023 | Desara |
| Amag Pharmaceuticals, INC. | $61.02 | 2019 | |
| Amgen INC. | $59.56 | 2020-2023 | Prolia, Evenity |
| Exeltis, USA INC. | $59.49 | 2021-2023 | Slynd |
| Biogen, INC. | $48.47 | 2025 | Zurzuvae |
| Aspira Women'S Health INC | $43.33 | 2022 | |
| Abbott Laboratories | $42.96 | 2023-2024 | Proclaim |
| Agile Therapeutics, INC. | $40.23 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.33 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $34.62 | 2019-2020 | |
| Smith+Nephew, INC. | $30.03 | 2022 | |
| Novo Nordisk INC | $29.27 | 2020-2023 | |
| Organogenesis INC. | $27.05 | 2025 | Puraply Wound Matrix |
| Medtronic, INC. | $26.02 | 2024 | V-Loc 180 |
| Lilly USA, LLC | $22.16 | 2025 | Zepbound |
| Lupin INC. | $19.20 | 2020 | |
| Covidien Lp | $15.58 | 2019 | |
| Meditrina | $9.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naved Jafri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.